(Q37554194)

21 August 2017

1 reference

title

Diabetes mellitus and gastric emptying: questions and issues in clinical practice (English)

1 reference

21 August 2017

3

John E Gerich

1 reference

21 August 2017

Melvin Samsom

1

1 reference

21 August 2017

Adil Bharucha

2

1 reference

21 August 2017

Kathrin Herrmann

4

1 reference

21 August 2017

Jörg Limmer

5

1 reference

21 August 2017

Rainer Linke

6

1 reference

21 August 2017

David Maggs

7

1 reference

21 August 2017

Jörg Schirra

8

1 reference

21 August 2017

Adrian Vella

9

1 reference

21 August 2017

Hans-Jürgen Wörle

10

1 reference

21 August 2017

Burkhard Göke

11

1 reference

21 August 2017

1 September 2009

1 reference

Diabetes - Metabolism: Research and Reviews

21 August 2017

1 reference

21 August 2017

25

1 reference

21 August 2017

6

1 reference

21 August 2017

502-514

1 reference

Gastrointestinal motor mechanisms in hyperglycaemia induced delayed gastric emptying in type I diabetes mellitus

21 August 2017

1 reference

The effect of laboratory stressors on glycemic control and gastrointestinal transit time.

21 January 2018

1 reference

Upper gastrointestinal function and glycemic control in diabetes mellitus

21 January 2018

1 reference

21 January 2018

1 reference

The possible role of postprandial hyperglycaemia in the pathogenesis of diabetic complications

21 January 2018

1 reference

Pharmacological actions of the peptide hormone amylin in the long-term regulation of food intake, food preference, and body weight

21 January 2018

1 reference

Prevalence of gastrointestinal symptoms associated with diabetes mellitus: a population-based survey of 15,000 adults

21 January 2018

1 reference

7 January 2021

Upper gastrointestinal symptoms in a U.S. national sample of adults with diabetes.

1 reference

7 January 2021

Proximal gastric motor activity in response to a liquid meal in type I diabetes mellitus with autonomic neuropathy.

1 reference

7 January 2021

Disordered gastric motor function in diabetes mellitus

1 reference

7 January 2021

Predictors of delayed gastric emptying in diabetes

1 reference

7 January 2021

Prevalence of delayed gastric emptying in diabetic patients and relationship to dyspeptic symptoms: a prospective study in unselected diabetic patients

1 reference

7 January 2021

Relationships between oesophageal transit and solid and liquid gastric emptying in diabetes mellitus

1 reference

7 January 2021

Gastrointestinal symptoms in middle-aged diabetic patients

1 reference

7 January 2021

Gastrointestinal tract symptoms among persons with diabetes mellitus in the community.

1 reference

7 January 2021

Autonomic dysfunction in gastrointestinal motility disorders

1 reference

7 January 2021

Relationships of upper gastrointestinal motor and sensory function with glycemic control

1 reference

7 January 2021

Increased prevalence of upper gastrointestinal symptoms in long-term type 1 diabetes mellitus

1 reference

7 January 2021

Serum glucose concentration as a modulator of interdigestive gastric motility

1 reference

7 January 2021

Gastric emptying and release of incretin hormones after glucose ingestion in humans

1 reference

7 January 2021

Hypoglycaemia increases the gastric emptying rate in patients with type 1 diabetes mellitus

1 reference

7 January 2021

Euglycaemic hyperinsulinaemia does not affect gastric emptying in Type I and Type II diabetes mellitus

1 reference

7 January 2021

Rapid gastric emptying in patients with early non-insulin-dependent diabetes mellitus

1 reference

7 January 2021

Mechanism of accelerated gastric emptying of liquids and hyperglycemia in patients with type II diabetes mellitus

1 reference

7 January 2021

Prevalence and determinants of solid and liquid gastric emptying in unstable type I diabetes. Relationship to postprandial blood glucose concentrations

1 reference

7 January 2021

Highly variable gastric emptying in patients with insulin dependent diabetes mellitus

1 reference

7 January 2021

Gastrointestinal transit disorders in patients with insulin-treated diabetes mellitus

1 reference

7 January 2021

[13C]octanoic acid breath test for non-invasive assessment of gastric emptying in diabetic patients: validation and relationship to gastric symptoms and cardiovascular autonomic function

1 reference

7 January 2021

Rapid gastric emptying of a solid pancake meal in type II diabetic patients.

1 reference

7 January 2021

Role of hyperglycemia in nitrotyrosine postprandial generation

1 reference

7 January 2021

Effect of postprandial hypertriglyceridemia and hyperglycemia on circulating adhesion molecules and oxidative stress generation and the possible role of simvastatin treatment

1 reference

7 January 2021

Should postprandial hyperglycaemia in prediabetic and type 2 diabetic patients be treated?

1 reference

7 January 2021

Regression of carotid atherosclerosis by control of postprandial hyperglycemia in type 2 diabetes mellitus.

1 reference

7 January 2021

Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress

1 reference

7 January 2021

GLP-1 receptor agonists and DPP-4 inhibitors in the treatment of type 2 diabetes

1 reference

7 January 2021

GLP-1 based therapy for type 2 diabetes

1 reference

7 January 2021

Exenatide: a GLP-1 receptor agonist as novel therapy for Type 2 diabetes mellitus

1 reference

7 January 2021

GLP-1 and type 2 diabetes: physiology and new clinical advances

1 reference

7 January 2021

Therapeutic intervention in the GLP-1 pathway in Type 2 diabetes.

1 reference

7 January 2021

Amylin replacement with pramlintide as an adjunct to insulin therapy in type 1 and type 2 diabetes mellitus: a physiological approach toward improved metabolic control

1 reference

7 January 2021

Gastric emptying in normal subjects--a reproducible technique using a single scintillation camera and computer system

1 reference

7 January 2021

Gastric emptying of varying meal weight and composition in man. Evaluation by dual liquid- and solid-phase isotopic method

1 reference

7 January 2021

Relationship between oral glucose tolerance and gastric emptying in normal healthy subjects

1 reference

7 January 2021

Load-dependent effects of duodenal glucose on glycemia, gastrointestinal hormones, antropyloroduodenal motility, and energy intake in healthy men

1 reference

7 January 2021

Control of gastric emptying

1 reference

7 January 2021

Skeletal muscle glycolysis, oxidation, and storage of an oral glucose load

1 reference

7 January 2021

Effects of glucagon-like peptide-1 and feeding on gastric volumes in diabetes mellitus with cardio-vagal dysfunction.

1 reference

7 January 2021

Disordered gastric emptying: mechanical basis, assessment and treatment

1 reference

7 January 2021

Role of the kidney in hyperglycemia in type 2 diabetes

1 reference

7 January 2021

Abnormal meal carbohydrate disposition in insulin-dependent diabetes. Relative contributions of endogenous glucose production and initial splanchnic uptake and effect of intensive insulin therapy

1 reference

7 January 2021

Postprandial serum glucose, insulin, and lipoprotein responses to high- and low-fiber diets

1 reference

7 January 2021

Effects of varying carbohydrate content of diet in patients with non-insulin-dependent diabetes mellitus

1 reference

7 January 2021

Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: variations with increasing levels of HbA(1c).

1 reference

7 January 2021

Hyperglycaemia affects proximal gastric motor and sensory function in normal subjects.

1 reference

7 January 2021

Pathogenesis and treatment of type 2 (noninsulin-dependent) diabetes mellitus (NIDDM).

1 reference

7 January 2021

Insulin-induced hypoglycemia accelerates gastric emptying of solids and liquids in long-standing type 1 diabetes

1 reference

7 January 2021

Relationships between hypoglycaemia and gastric emptying abnormalities in insulin-treated diabetic patients

1 reference

7 January 2021

'Gastric' hypoglycaemia - an important concept in diabetes management

1 reference

7 January 2021

Physiological hyperglycemia slows gastric emptying in normal subjects and patients with insulin-dependent diabetes mellitus

1 reference

7 January 2021

Impaired hyperglycemia-induced delay in gastric emptying in patients with type 1 diabetes deficient for islet amyloid polypeptide

1 reference

7 January 2021

Compliance of the proximal stomach and dyspeptic symptoms in patients with type I diabetes mellitus

1 reference

7 January 2021

Delayed gastric emptying rate in Type 1 diabetics with cardiac autonomic neuropathy

1 reference

7 January 2021

Hypoglycemia increases the gastric emptying rate in healthy subjects

1 reference

7 January 2021

Hypoglycemia overrides amylin-mediated regulation of gastric emptying in rats

1 reference

7 January 2021

Gastric and oesophageal emptying in patients with type 2 (non-insulin-dependent) diabetes mellitus

1 reference

7 January 2021

Simultaneous measurement of gastric emptying of a solid meal by ultrasound and by scintigraphy

1 reference

7 January 2021

Scintigraphic validation of a magnetic resonance imaging method to study gastric emptying of a solid meal in humans

1 reference

7 January 2021

Measurement of gastric emptying rate of solids by means of a carbon-labeled octanoic acid breath test.

1 reference

7 January 2021

Measurement of gastric emptying by magnetic resonance imaging in humans

1 reference

7 January 2021

American Gastroenterological Association technical review on the diagnosis and treatment of gastroparesis

1 reference

7 January 2021

Insulin restores neuronal nitric oxide synthase expression and function that is lost in diabetic gastropathy.

1 reference

7 January 2021

A deficiency of gastric interstitial cells of Cajal accompanied by decreased expression of neuronal nitric oxide synthase and substance P in patients with type 2 diabetes mellitus

1 reference

7 January 2021

Diabetes induces sex-dependent changes in neuronal nitric oxide synthase dimerization and function in the rat gastric antrum

1 reference

7 January 2021

Blood glucose concentration influences postprandial fullness in IDDM.

1 reference

7 January 2021

Gastric emptying in diabetes

1 reference

7 January 2021

Idiopathic and Diabetic Gastroparesis

1 reference

7 January 2021

Diabetic autonomic neuropathy

1 reference

7 January 2021

A review of diabetic gastropathy

1 reference

7 January 2021

Gastric neuropathy in diabetes mellitus: clinical and radiologic observations

1 reference

7 January 2021

American Gastroenterological Association medical position statement: diagnosis and treatment of gastroparesis

1 reference

7 January 2021

Consensus recommendations for gastric emptying scintigraphy: a joint report of the American Neurogastroenterology and Motility Society and the Society of Nuclear Medicine

1 reference

7 January 2021

Assessment of gastric emptying using a low fat meal: establishment of international control values

1 reference

7 January 2021

Standardization of a simplified scintigraphic methodology for the assessment of gastric emptying in a multicenter setting

1 reference

7 January 2021

Measurement of gastric emptying by 13C-octanoic acid breath test versus scintigraphy in diabetics.

1 reference

7 January 2021

Toward office-based measurement of gastric emptying in symptomatic diabetics using [13C]octanoic acid breath test

1 reference

7 January 2021

Effects of pramlintide, an amylin analogue, on gastric emptying in type 1 and 2 diabetes mellitus

1 reference

7 January 2021

A stable isotope breath test with a standard meal for abnormal gastric emptying of solids in the clinic and in research

1 reference

7 January 2021

Novel testing of human gastric motor and sensory functions: rationale, methods, and potential applications in clinical practice

1 reference

7 January 2021

Ultrasonography of the human stomach.

1 reference

7 January 2021

Scintigraphic measurement of gastric emptying and ultrasonographic assessment of antral area: relation to appetite

1 reference

7 January 2021

Comparison of gastric emptying of a nondigestible capsule to a radio-labelled meal in healthy and gastroparetic subjects

1 reference

7 January 2021

Improvement of gastric emptying in diabetic gastroparesis by erythromycin. Preliminary studies

1 reference

7 January 2021

Effects of low doses of erythromycin on the 13C Spirulina platensis gastric emptying breath test and electrogastrogram: a controlled study in healthy volunteers.

1 reference

7 January 2021

Erythromycin derivative improves gastric emptying and insulin requirement in diabetic patients with gastroparesis.

1 reference

7 January 2021

Effect of altering gastric emptying on postprandial plasma glucose concentrations following a physiologic meal in type-II diabetic patients

1 reference

7 January 2021

Ghrelin enhances gastric emptying in diabetic gastroparesis: a double blind, placebo controlled, crossover study.

1 reference

7 January 2021

Effect of oral CCK-1 agonist GI181771X on fasting and postprandial gastric functions in healthy volunteers

1 reference

7 January 2021

No ghrelin response to oral glucose in diabetes mellitus with gastroparesis

1 reference

7 January 2021

Effect of gastrin on proximal gastric motor function in humans.

1 reference

7 January 2021

Gastroparesis: clinical update

1 reference

7 January 2021

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

7 January 2021

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

7 January 2021

Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes

1 reference

7 January 2021

Impact of insulin on microvascular blood flow and endothelial cell function in the postprandial state in patients with Type 1 diabetes

1 reference

7 January 2021

What does postprandial hyperglycaemia mean?

1 reference

7 January 2021

Effects of fat on gastric emptying of and the glycemic, insulin, and incretin responses to a carbohydrate meal in type 2 diabetes

1 reference

7 January 2021

Effects of pramlintide on postprandial glucose excursions and measures of oxidative stress in patients with type 1 diabetes

1 reference

7 January 2021

Effects of exenatide (exendin-4) on glycemic control over 30 weeks in sulfonylurea-treated patients with type 2 diabetes

1 reference

7 January 2021

Effects of exenatide (exendin-4) on glycemic control and weight over 30 weeks in metformin-treated patients with type 2 diabetes

1 reference

7 January 2021

Effects of exenatide (exendin-4) on glycemic control over 30 weeks in patients with type 2 diabetes treated with metformin and a sulfonylurea

1 reference

7 January 2021

The effect of single doses of pramlintide on gastric emptying of two meals in men with IDDM.

1 reference

7 January 2021

Pramlintide, an amylin analog, selectively delays gastric emptying: potential role of vagal inhibition

1 reference

7 January 2021

Dose-response for glucagonostatic effect of amylin in rats

1 reference

7 January 2021

Amylin concentrations and glucose control

1 reference

7 January 2021

Unresolved challenges with insulin therapy in type 1 and type 2 diabetes: potential benefit of replacing amylin, a second beta-cell hormone

1 reference

7 January 2021

The human amylin analog, pramlintide, reduces postprandial hyperglucagonemia in patients with type 2 diabetes mellitus

1 reference

7 January 2021

Pramlintide: a human amylin analogue reduced postprandial plasma glucose, insulin, and C-peptide concentrations in patients with type 2 diabetes

1 reference

7 January 2021

Effects of pramlintide, an analog of human amylin, on plasma glucose profiles in patients with IDDM: results of a multicenter trial

1 reference

7 January 2021

A randomized study and open-label extension evaluating the long-term efficacy of pramlintide as an adjunct to insulin therapy in type 1 diabetes

1 reference

7 January 2021

Pharmacokinetics of an oral drug (acetaminophen) administered at various times relative to subcutaneous injection of pramlintide in subjects with type 2 diabetes

1 reference

7 January 2021

Importance of changes in gastric emptying for postprandial plasma glucose fluxes in healthy humans

1 reference

7 January 2021

Infusion of pramlintide, a human amylin analogue, delays gastric emptying in men with IDDM

1 reference

7 January 2021

Glucagon-like peptide 1: evolution of an incretin into a treatment for diabetes

1 reference

7 January 2021

The effect of physiological levels of glucagon-like peptide-1 on appetite, gastric emptying, energy and substrate metabolism in obesity

1 reference

7 January 2021

Effects of glucagon-like peptide-1(7-36)amide on antro-pyloro-duodenal motility in the interdigestive state and with duodenal lipid perfusion in humans

1 reference

7 January 2021

Glucagon-like peptide-1 and the islet beta-cell: augmentation of cell proliferation and inhibition of apoptosis

1 reference

7 January 2021

Mechanisms of the antidiabetic action of subcutaneous glucagon-like peptide-1(7-36)amide in non-insulin dependent diabetes mellitus

1 reference

7 January 2021

Effects of glucagon-like peptide-1(7-36)amide on motility and sensation of the proximal stomach in humans

1 reference

7 January 2021

Endogenous glucagon-like peptide 1 controls endocrine pancreatic secretion and antro-pyloro-duodenal motility in humans

1 reference

7 January 2021

To be or not to be--an incretin or enterogastrone?

1 reference

7 January 2021

Mechanism of action of exenatide to reduce postprandial hyperglycemia in type 2 diabetes

1 reference

7 January 2021

Role of incretin hormones in the regulation of insulin secretion in diabetic and nondiabetic humans

1 reference

7 January 2021

Exenatide augments first- and second-phase insulin secretion in response to intravenous glucose in subjects with type 2 diabetes

1 reference

7 January 2021

Effect of exenatide on gastric emptying and relationship to postprandial glycemia in type 2 diabetes

1 reference

7 January 2021

Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-label, non-inferiority study

1 reference

7 January 2021

Pharmacokinetics, pharmacodynamics, safety, and tolerability of a single-dose of NN2211, a long-acting glucagon-like peptide 1 derivative, in healthy male subjects

1 reference

7 January 2021

The pharmacokinetics, pharmacodynamics, safety and tolerability of NN2211, a new long-acting GLP-1 derivative, in healthy men.

1 reference

7 January 2021

Efficacy and safety of the human glucagon-like peptide-1 analog liraglutide in combination with metformin and thiazolidinedione in patients with type 2 diabetes (LEAD-4 Met+TZD).

1 reference

7 January 2021

Efficacy and safety comparison of liraglutide, glimepiride, and placebo, all in combination with metformin, in type 2 diabetes: the LEAD (liraglutide effect and action in diabetes)-2 study

1 reference

7 January 2021

Liraglutide versus glimepiride monotherapy for type 2 diabetes (LEAD-3 Mono): a randomised, 52-week, phase III, double-blind, parallel-treatment trial

1 reference

7 January 2021

The effect of liraglutide, a long-acting glucagon-like peptide 1 derivative, on glycemic control, body composition, and 24-h energy expenditure in patients with type 2 diabetes

1 reference

7 January 2021

Improved glycemic control with no weight increase in patients with type 2 diabetes after once-daily treatment with the long-acting glucagon-like peptide 1 analog liraglutide (NN2211): a 12-week, double-blind, randomized, controlled trial

1 reference

7 January 2021

Bedtime administration of NN2211, a long-acting GLP-1 derivative, substantially reduces fasting and postprandial glycemia in type 2 diabetes

1 reference

7 January 2021

One week's treatment with the long-acting glucagon-like peptide 1 derivative liraglutide (NN2211) markedly improves 24-h glycemia and alpha- and beta-cell function and reduces endogenous glucose release in patients with type 2 diabetes.

1 reference

7 January 2021

Liraglutide, a long-acting human glucagon-like peptide-1 analog, given as monotherapy significantly improves glycemic control and lowers body weight without risk of hypoglycemia in patients with type 2 diabetes

1 reference

7 January 2021

Identifiers

DOI

10.1002/DMRR.974

1 reference

21 August 2017

1 reference